Tesla
TSLA
NVIDIA
NVDA
Apple
AAPL
Oracle
ORCL
Cisco
CSCO
US Stock MarketDetailed Quotes
CTNM Contineum Therapeutics
- 7.459
- -0.031-0.41%
Trading Mar 19 09:40 ET
192.98MMarket Cap-4.56P/E (TTM)
7.550High7.068Low1.15KVolume7.490Open7.490Pre Close8.52KTurnover0.01%Turnover RatioLossP/E (Static)25.87MShares22.00052wk High0.97P/B97.94MFloat Cap5.92052wk Low--Dividend TTM13.13MShs Float22.000Historical High--Div YieldTTM6.44%Amplitude5.920Historical Low7.417Avg Price1Lot Size
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Contineum Therapeutics Stock Forum
Can Contineum's $204M War Chest Deliver 6 Clinical Trial Wins? Key Dates Revealed
NEWS
Contineum Therapeutics, Inc. announces pricing of IPO, offering 6,875,000 shares of Class A common stock at $16.00 per share, expecting gross proceeds of $110.0 million. Shares to trade on Nasdaq under symbol 'CTNM'.
No comment yet